(Q37279958)

19 August 2017

1 reference

title

In vitro assays for the evaluation of drug resistance in tumor cells (English)

1 reference

19 August 2017

Jozef Hatok

1

1 reference

19 August 2017

Eva Babusikova

2

1 reference

19 August 2017

Tatiana Matakova

3

1 reference

19 August 2017

Dusan Mistuna

4

1 reference

19 August 2017

Dusan Dobrota

5

1 reference

19 August 2017

Peter Racay

6

1 reference

19 August 2017

publication date

26 September 2008

1 reference

Clinical and Experimental Medicine

19 August 2017

published in

1 reference

19 August 2017

volume

9

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

1-7

1 reference

https://scigraph.springernature.com/pub.10.1007/s10238-008-0011-3

19 August 2017

exact match

0 references

cites work

Effects of cancer chemotherapeutic agents on dehydrogenase activity of human cancer tissue in vitro.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10238-008-0011-3

Application of an in vitro antimetabolic assay to human germ cell testicular tumors for the preclinical evaluation of drug sensitivity.

21 January 2018

1 reference

12 December 2020

Limitations of the fluorescent probe viability assay.

1 reference

12 December 2020

Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures.

1 reference

12 December 2020

In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions.

1 reference

12 December 2020

Chemosensitivity testing predicts survival in ovarian cancer.

1 reference

12 December 2020

In vitro chemosensitivity testing of selected myeloid cells in acute myeloid leukemia

1 reference

12 December 2020

Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma

1 reference

12 December 2020

In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.

1 reference

12 December 2020

Use of in vitro tests in predictive cancer chemotherapy

1 reference

12 December 2020

Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT.

1 reference

12 December 2020

Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined DiSC assay methodology

1 reference

12 December 2020

Extreme drug resistance is common after prior exposure to paclitaxel

1 reference

12 December 2020

Prospective clinical trial of a human tumor cloning system

1 reference

12 December 2020

Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer.

1 reference

12 December 2020

American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays

1 reference

12 December 2020

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines

1 reference

12 December 2020

Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements

1 reference

12 December 2020

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

12 December 2020

Acid phosphatase: endpoint for in vitro toxicity tests

1 reference

12 December 2020

Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia.

1 reference

12 December 2020

Cytogenetic abnormalities of small round cell tumours

1 reference

12 December 2020

Heterogeneity of drug resistance in human breast and ovarian cancers

1 reference

12 December 2020

The DiSC assay. A cost-effective guide to treatment for chronic lymphocytic leukemia?

1 reference

12 December 2020

The use of the MTT assay to study drug resistance in fresh tumour samples.

1 reference

12 December 2020

Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma

1 reference

12 December 2020

Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician

1 reference

12 December 2020

Application of radioactive precursors for the evaluation of sensitivity of cancer cells to anticancer drugs.

1 reference

12 December 2020

Chemotherapy sensitivity and resistance assays: a systematic review

1 reference

12 December 2020

Primary Bioassay of Human Tumor Stem Cells

1 reference

12 December 2020

Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test.

1 reference

12 December 2020

Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity

1 reference

12 December 2020

In vitro chemosensitivity testing of leukemic cells: prediction of response to chemotherapy in patients with acute non-lymphocytic leukemia.

1 reference

12 December 2020

Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

1 reference

12 December 2020

Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro.

1 reference

12 December 2020

Drug sensitivity assays in leukaemia and lymphoma

1 reference

12 December 2020

Comparison of a bioluminescence assay with differential staining cytotoxicity for cytostatic drug testing in vitro in human leukemic cells.

1 reference

12 December 2020

10.1007/S10238-008-0011-3

Identifiers

DOI

1 reference

19 August 2017

1 reference